Trump Admin May Cut $3.6B Medicare Part D Subsidy, Hitting CVS
CVS sits 71% above its 52-week low of $61.19.
Summary
The Trump administration is reportedly considering ending a ~$3.6 billion Medicare Part D subsidy, a move that would directly reduce revenue for insurers with large Part D enrollment like CVS Health's Aetna unit. Shares slipped after-hours on the report. This follows a series of positive developments for CVS, including raised 2026 EPS guidance and Medicare Advantage rate increases, but the subsidy risk introduces a material headwind. Separately, CVS removed store-brand sunscreens below SPF 30 and invested $10 million in a Massachusetts affordable senior housing project, though these are minor relative to the Part D threat. The subsidy decision remains uncertain, but if implemented, it could pressure earnings for a key segment.
At the time of this announcement, CVS was trading at $104.56 on NYSE in the Trade & Services sector, with a market capitalization of approximately $133.2B. The 52-week trading range was $61.19 to $110.68. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.